Richtlijn Diabetische retinopathie - Nederlands Oogheelkundig ...

S c r e e n i n g21. Herbert HM, Jordan K, Flanagan DW. Is screening with digital imaging using one retinal view adequate? Eye2003;17:497-500.22. Scanlon PH, et al. The effectiveness of screening for diabetic retinopathy by digital imaging photography andtechnician ophthalmoscopy. Diabet Med 2003;20:467-74.23. Maberley D, Cruess AF, Barile G, Slakter J. Digital photographic screening for diabetic retinopathy in the JamesBay Cree. Ophthalmic Epidemiol 2002;9(3):169-78.24. Taylor DJ, Fisher J, Jacob J, Tooke JE. The use of digital cameras in a mobile retinal screening environment. DiabetMed 1999;16:680-6.25. Fransen SR, Leonard-Martin TC, Feuer, WJ, Hildebrand PL, and The Inoveon Health Research Group. ClinicalEvaluation of Patients with Diabetic Retinopathy. Ophthalmol 2002;109:595-601.26. Pandit R, Taylor R. Mydriasis and glaucoma: exploding the myth. Diabet Med 2000;17:693-9.27. Stilma JS. Oogheelkunde, Praktische Huisartsgeneeskunde. Bohn Stafleu Van Loghum, Houten/Mechelen, 2002.28. Polak BCP, Bijl D. Bijwerkingen van geneesmiddelen in de oogheelkunde. Geneesmiddelenbulletin 2002;36(6): 63-9.29. Davis MD, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early TreatmentDiabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 1998;39(2):233-52.30. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy.II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol1984;102(4):520-6.31. Bonney M, Hing SJ, Fung AT, Stephens MM, Fairchild JM, Donaghue KC, et al. Development and progression ofdiabetic retinopathy: adolescents at risk. Diabet Med 1995;12(11):967-73.32. Frank RN, Hoffman WH, Podgor MJ, Joondeph HC, Lewis RA, Margherio RR, et al. Retinopathy in juvenile-onsetdiabetes of short duration. Ophthalmol 1980;87(1):1-9.33. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy.III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol1984;102(4):527-32.34. Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992;15(12):1875-91.35. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis.Diabetes Care 1992;15(7):815-9.36. Younis N, Broadbent DM, Vora JP, Harding SP. Liverpool Diabetic Eye Study. Incidence of sight-threatening retinopathyin patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003;361(9353):195-200.37. Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients withtype 2 diabetes mellitus. JAMA 2000 Feb 16;283(7):889-96.38. Kohner EM, Stratton IM, Aldington SJ, Holman RR, Matthews DR. Relationship between the severity of retinopathyand progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52).Diabet Med 2001 Mar;18(3):178-84.- Stellingwerf C, Hardus PLLJ, Hooymans JMM. Assessing diabetic retinopathy using two-field digital photographyand the influence of JPEG-compression. Doc Ophthalmol 2004;108:203-9.- Crijns H. Diabetic retinopathy. Proefschrift. Erasmus Universiteit, Rotterdam; 1993.- Polak BCP, Crijns H, Casparie AF, Niessen LW. Cost-effectiveness of glycemic control and ophthalmological carein diabetic retinopathy. Health Policy 2003;64: 89-97.- Polak BCP. Ophthalmological complications of hemodialysis and kidney transplantation. Proefschrift. RijksuniversiteitLeiden; 1980.55